Differential modulation of paclitaxel-mediated apoptosis by p21(Waf1) and p27(Kip1)

Oncogene

Volumn 19, Issue 20, 2000, Pages 2423-2429

  Schmidt, Mathias ^a   Lu, Yang ^a   Liu, Bolin ^a   Fang, Min ^a   Mendelsohn, John ^a   Fan, Zhen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cell cycle; p21(Waf1); p27(Kip1); Paclitaxel: chemoresistance

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; ECDYSONE; PACLITAXEL; PROTEIN KINASE; PROTEIN P21; PROTEIN P27;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034636445     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203546     Document Type: Article

References (33)

1. Amato SF, Swart JM, Berg M, Wanebo HJ, Mehta SR and Chiles TC. (1998). Cancer Res., 58, 241-247.
2. Blagosklonny MV, Giannakakou P, el-Deiry WS, Kingston DG, Higgs PI, Neckers L and Fojo T. (1997). Cancer Res., 57, 130-135.
3. Blagosklonny MV, Schulte T, Nguyen P, Trepel J and Neckers LM. (1996). Cancer Res., 56, 1851-1854.
4. Cayrol C, Knibiehler M and Ducommun B. (1998). Oncogene, 16, 311-320.
5. Donaldson KL, Goolsby GL, Kiener PA and Wahl AF. (1994). Cell Growth Differ., 5, 1041-1050.
6. Dulic V, Stein GH, Far DF and Reed SI. (1998). Mol. Cell. Biol., 18, 546-557.
7. Fan Z, Lu Y, Wu X, DeBlasio A, Koff A and Mendelsohn J. (1995). J. Cell Biol., 131, 235-242.
8. Frankel A, Buckman R and Kerbel RS. (1997). Cancer Res., 57, 2388-2393.
9. Haldar S, Chintapalli J and Croce CM. (1996). Cancer Res., 56, 1253-1255.
10. Horwitz SB. (1992). Trends Pharmacol. Sci., 13, 134-136.
11. Ibrado AM, Liu L and Bhalla K. (1997). Cancer Res., 57, 1109-1115.
12. Kapoor M and Lozano G. (1998). Proc. Natl. Acad. Sci. USA, 95, 2834-2837.
13. Larsen JK, Munch-Petersen B, Christiansen J and Jorgensen K. (1986). Cytometry, 7, 54-63.
14. Lee LF, Li G, Templeton DJ and Ting JP. (1998). J. Biol. Chem., 273, 28253-28260.
15. Li W, Fan J, Banerjee D and Bertino JR. (1999). Mol. Pharmacol., 55, 1088-1093.
16. Ling YH, Tornos C and Perez-Soler R. (1998). J. Biol. Chem., 273, 18984-18991.
17. Medema RH, Klompmaker R, Smits VA and Rijksen G. (1998). Oncogene, 16, 431-441.
18. Niculescu AB, Chen X, Smeets M, Hengst L, Prives C and Reed SI. (1998). Mol. Cell. Biol., 18, 629-643.
19. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A. (1994). Genes Dev., 8, 9-22.
20. Rakovitch E, Mellado W, Hall EJ, Pandita TK, Sawant S and Geard CR. (1999). Int. J Radiat. Oncol. Biol. Phys., 44, 1119-1124.
21. Rowinsky EK. (1997). Semin. Oncol., 24 (Suppl 19), 1-12.
22. Schiff PB and Horwitz SB. (1980). Proc. Natl. Acad. Sci. USA, 77, 1561-1565.
23. Shen SC, Huang TS, Jee SH and Kuo ML. (1998). Cell Growth Differ., 9, 23-29.
24. Sorger PK, Dobles M, Tournebize R and Hyman AA. (1997). Curr. Opin. Cell Biol., 9, 807-814.
25. Strobel T, Swanson L, Korsmeyer S and Cannistra SA. (1996). Proc. Natl. Acad. Sci. USA, 93, 14094-14099.
26. Sumantran VN, Ealovega MW, Nunez G, Clarke MF and Wicha MS. (1995). Cancer Res., 55, 2507-2510.
27. Toyoshima H and Hunter T. (1994). Cell, 78, 67-74.
28. Uren A, Jakus J, de MF, Yeudall A, Santos E, Gutkind S and Heidaran MA. (1997). J. Biol. Chem., 272, 21669-21672.
29. van Bree C, van der Maat B, Ceha HM, Franken NA, Haveman J and Bakker PJ. (1999). J. Cancer Res. Clin. Oncol., 125, 549-555.
30. Verlhac MH, de Pennart H, Maro B, Cobb MH and Clarke HJ. (1993). Dev. Biol., 158, 330-340.
31. Wang TH, Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T and Wimalasena J. (1998). J. Biol. Chem., 273, 4928-4936.
32. Wu X, Rubin M, Fan Z, DeBlasio T, Soos T, Koff A and Mendelsohn J. (1996). Oncogene, 12, 1397-1403.
33. Yu D, Jing T, Liu B, Yao J, Tan M, McDonnell TJ and Hung MC. (1998). Mol. Cell. 2, 581-591.